## Clinical Context This patient has community-acquired pneumonia (CAP) with moderate-to-severe features: hypoxemia (SpO₂ 88%), tachypnea (RR 24), and underlying COPD. The CURB-65 score is ≥2 (confusion absent, urea unknown, respiratory rate ≥30 — no, HR ≥120 — no, age ≥65 — no, but SpO₂ <90% is a severity marker), warranting hospital admission and empirical broad-spectrum coverage. ## Management Algorithm ```mermaid flowchart TD A[CAP diagnosis confirmed]:::outcome --> B{Severity assessment}:::decision B -->|Mild, outpatient| C[Amoxicillin or doxycycline]:::action B -->|Moderate-severe, hospitalized| D[Hypoxemia present?]:::decision D -->|Yes| E[Supplemental O₂ target SpO₂ ≥90%]:::action E --> F[Blood + sputum cultures]:::action F --> G[Empirical: 3rd-gen cephalosporin + macrolide]:::action B -->|Severe, ICU| H[Respiratory support + broad-spectrum]:::urgent ``` ## Why Option 1 is Correct **Key Point:** In moderate-to-severe CAP with hypoxemia, the immediate priorities are: 1. Oxygenation (SpO₂ ≥90% reduces mortality) 2. Microbiological sampling (blood and sputum cultures before antibiotics) 3. Empirical broad-spectrum coverage (3rd-generation cephalosporin + macrolide covers *Streptococcus pneumoniae*, *Haemophilus influenzae*, atypical organisms, and gram-negatives) **High-Yield:** Delay in antibiotic initiation in moderate-to-severe CAP increases mortality. However, cultures must be obtained *before* antibiotics are given to guide de-escalation therapy [cite:Harrison 21e Ch 297]. **Clinical Pearl:** The combination of cephalosporin + macrolide is the standard empirical regimen for hospitalized CAP in India, covering the most common pathogens and atypical organisms (especially *Mycoplasma* and *Chlamydia*). ## Why Other Options Are Wrong **Amoxicillin-clavulanate alone (Option 0):** Inadequate coverage for atypical organisms and gram-negatives in hospitalized CAP; does not address hypoxemia urgently. **CT chest before antibiotics (Option 2):** Delays critical antibiotic therapy; CT is not indicated for uncomplicated CAP diagnosis. Imaging may be considered later if clinical deterioration or atypical features emerge. **Observation without antibiotics (Option 3):** Contradicts evidence-based guidelines; delays treatment and increases mortality risk in moderate-to-severe CAP with hypoxemia.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.